Literature DB >> 16868833

Assessment of portal hemodynamics by Doppler ultrasound and of liver morphology in the hepatosplenic and hepatointestinal forms of schistosomiasis mansoni.

Denise Cerqueira Paranaguá Vezozzo1, Alberto Queiroz Farias, Giovanni Guido Cerri, Luiz Caetano Da Silva, Flair José Carrilho.   

Abstract

The aim of this study was to compare portal and splenic blood flows and the liver morphology in hepatosplenic (HS) and hepatointestinal (HI) schistosomiasis. Doppler ultrasound measurements were performed in 48 adult patients with schistosomiasis, according to the criteria of the World Health Organization, and compared with those performed in 20 healthy controls. Portal flow was significantly higher (P < 0.0001) in both HS and HI (2481 +/- 1467 and 2159 +/- 1446 ml/min, respectively) than in normal individuals (842 +/- 322 ml/min). There was no difference in splenic blood flow (822 +/- 685 and 458 +/- 292 ml/min, respectively) between HS and HI, but these values were significantly higher than those of normal controls (243 +/- 94 ml/min). Portal and splenic overflow are found in both the HS and the HI forms of schistosomiasis.

Entities:  

Mesh:

Year:  2006        PMID: 16868833     DOI: 10.1007/s10620-005-9020-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  6 in total

Review 1.  The WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.

Authors:  Tarik el Scheich; Martha C Holtfreter; Hendrik Ekamp; Daman D Singh; Rodrigo Mota; Christoph Hatz; Joachim Richter
Journal:  Parasitol Res       Date:  2014-09-27       Impact factor: 2.289

2.  Schistosomiasis mansoni: ultrasound-evaluated hepatic fibrosis and serum concentrations of hyaluronic acid.

Authors:  C C Silva; A L Domingues; E P Lopes; C N Morais; R B Santos; C F Luna; H B Nader; J R Martins
Journal:  Ann Trop Med Parasitol       Date:  2011-04

3.  Selectins and platelet-derived growth factor (PDGF) in schistosomiasis-associated pulmonary hypertension.

Authors:  Monica Lapa; Milena M P Acencio; Alberto Q Farias; Lisete R Teixeira; Caio J C Fernandes; Carlos P Jardim; Mario Terra-Filho
Journal:  Lung       Date:  2014-09-14       Impact factor: 2.584

4.  Endothelial markers in schistosomiasis patients with or without portal hypertension.

Authors:  Carlos Fischer de Toledo; Claudia Teresa Carvente; David Carlos Shigueoka; Durval Rosa Borges
Journal:  Dig Dis Sci       Date:  2008-08-27       Impact factor: 3.199

5.  Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with Schistosomiasis.

Authors:  Alexi Crosby; Elaine Soon; Frances M Jones; Mark R Southwood; Leila Haghighat; Mark R Toshner; Tim Raine; Ian Horan; Peiran Yang; Stephen Moore; Elisabet Ferrer; Penny Wright; Mark L Ormiston; R James White; Deborah A Haight; David W Dunne; Nicholas W Morrell
Journal:  Am J Respir Crit Care Med       Date:  2015-12-01       Impact factor: 21.405

6.  Intrapulmonary vascular dilatation evaluated by 99mTc-MAA scintigraphy and its association with portal hypertension in schistosomiasis.

Authors:  Andréa Simone Siqueira de Queirós; Simone Cristina Soares Brandão; Ana Lúcia Coutinho Domingues; Liana Gonçalves Macedo; Maira Souto Ourem; Edmundo Pessoa Almeida Lopes
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.